Literature DB >> 22176514

Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16.

Xiu-Feng Yan1, Shuang Gao, Ju-Feng Xia, Rong Ye, Hui Yu, Jian-Er Long.   

Abstract

BACKGROUND: Enterovirus 71 (EV71) has been the main causative agent of hand, foot, and mouth disease (HFMD) outbreaks in recent years. A significant increase in the number of HFMD cases in China over the last 3 y has made the public prevention and therapy of this disease a critical issue.
METHODS: A total of 3208 HFMD patients in Shanghai during the period 2009 to 2010 were analyzed; 437 clinical specimens were collected for the determination of causative pathogens. Eight of the isolated EV71 strains were sequenced and phylogenetically analyzed.
RESULTS: The widespread outbreak of HFMD in Shanghai was caused predominantly by EV71 (86.5%), and in part by coxsackievirus A16 (CA16) (6.9%). The high incidence of mixed infections with EV71 and CA16 (17.6% of the total CA16-infected cases) has never before been observed in China. Most HFMD patients (76.9%) were aged 1-4 y. Boys showed a higher HFMD prevalence rate (65.3%) than girls (34.7%). Phylogenetic analysis on the basis of the VP1 gene and the complete genome sequences revealed that the EV71 strains that circulated in Shanghai belonged to the C4 subgenotype.
CONCLUSIONS: EV71 subgenotype C4 was the major causative agent of the HFMD outbreak in Shanghai. A high incidence of mixed infections with EV71 and CA16 was also observed.

Entities:  

Mesh:

Year:  2011        PMID: 22176514     DOI: 10.3109/00365548.2011.634433

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  33 in total

Review 1.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

2.  Hand, foot, and mouth disease in China, 2008-12: an epidemiological study.

Authors:  Weijia Xing; Qiaohong Liao; Cécile Viboud; Jing Zhang; Junling Sun; Joseph T Wu; Zhaorui Chang; Fengfeng Liu; Vicky J Fang; Yingdong Zheng; Benjamin J Cowling; Jay K Varma; Jeremy J Farrar; Gabriel M Leung; Hongjie Yu
Journal:  Lancet Infect Dis       Date:  2014-01-31       Impact factor: 25.071

3.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

4.  Relationship between serologic response and clinical symptoms in children with enterovirus 71-infected hand-foot-mouth disease.

Authors:  Jun Shen; Chao Zhao; Ping Cao; Peng Shi; Lingfeng Cao; Qirong Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Severe hand, foot and mouth disease in Shenzhen, South China: what matters most?

Authors:  J Mou; M Dawes; Y Li; Y He; H Ma; X Xie; S Griffiths; J Cheng
Journal:  Epidemiol Infect       Date:  2013-07-01       Impact factor: 4.434

6.  Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine.

Authors:  Mohamed Ibrahim Saeed; Abd Rahaman Omar; Mohd Zobir Hussein; Isam Mohamed Elkhidir; Zamberi Sekawi
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

7.  Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou City, Jiangsu province, China, in 2012-2013.

Authors:  Chao Zhang; Rui Zhu; Yong Yang; Yudan Chi; Jieyun Yin; Xinying Tang; Luogang Yu; Chiyu Zhang; Zhong Huang; Dongming Zhou
Journal:  Emerg Microbes Infect       Date:  2015-02-25       Impact factor: 7.163

8.  An epidemic analysis of hand, foot, and mouth disease in Zunyi, China between 2012 and 2014.

Authors:  Weiwei Zhang; Bo Huang; Chaokun She; Yan Liu; Huabo Tong; Fengxue Wang; Kaifeng Wu
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

9.  Detecting spatial-temporal clusters of HFMD from 2007 to 2011 in Shandong Province, China.

Authors:  Yunxia Liu; Xianjun Wang; Yanxun Liu; Dapeng Sun; Shujun Ding; Bingbing Zhang; Zhaohui Du; Fuzhong Xue
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse.

Authors:  Chia-Ying Wu; Yi-Wen Lin; Chia-Ho Kuo; Wan-Hsin Liu; Hsiu-Fen Tai; Chien-Hung Pan; Yung-Tsung Chen; Pei-Wen Hsiao; Chi-Hsien Chan; Ching-Chuan Chang; Chung-Cheng Liu; Yen-Hung Chow; Juine-Ruey Chen
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.